Bicycle Therapeutics plc American Depositary Shares BCYC

$4.20 -3.00% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K FORM 8-K 2026-08-20 View →
10-Q 10-Q 2026-07-30 View →
8-K FORM 8-K 2026-07-30 View →
4 Insider transaction 2026-07-17 View →
4 Insider transaction 2026-07-17 View →
4 Insider transaction 2026-07-17 View →
4 Insider transaction 2026-07-17 View →
4 Insider transaction 2026-07-07 View →
4 Insider transaction 2026-07-07 View →
4 Insider transaction 2026-07-07 View →
4 Insider transaction 2026-07-07 View →
4 Insider transaction 2026-07-07 View →
8-K FORM 8-K 2026-06-18 View →
8-K FORM 8-K 2026-05-21 View →
10-Q 10-Q 2026-04-30 View →
8-K FORM 8-K 2026-04-30 View →
DEF 14A DEF 14A 2026-04-22 View →
8-K FORM 8-K 2026-04-20 View →
4 Insider transaction 2026-04-06 View →
4 Insider transaction 2026-04-06 View →
4 Insider transaction 2026-04-06 View →
4 Insider transaction 2026-04-06 View →
4 Insider transaction 2026-04-06 View →
10-K 10-K 2026-03-17 View →
8-K FORM 8-K 2026-03-17 View →
4 Insider transaction 2026-02-04 View →
8-K FORM 8-K 2026-02-03 View →
8-K FORM 8-K 2026-01-12 View →
4 Insider transaction 2026-01-06 View →
4 Insider transaction 2026-01-06 View →
4 Insider transaction 2026-01-06 View →
4 Insider transaction 2026-01-06 View →
4 Insider transaction 2026-01-06 View →
4 Insider transaction 2026-01-06 View →
4 Insider transaction 2026-01-06 View →
4 Insider transaction 2026-01-06 View →
4 Insider transaction 2026-01-06 View →
4 Insider transaction 2026-01-06 View →
4 Insider transaction 2026-01-06 View →
4 Insider transaction 2026-01-06 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$4.20
Market Cap
$303.07 million
52-Week Range
$3.75 $9.16
Average Volume
294K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.